ImmunoCellular (IMUC)
0.2702
+0.01 +2.12%
NYSE AM
Apr 19, 20:00
Real time
USD
View All Key Stats
IMUC Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.161 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -13.77M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 11.33M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.437 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -4.929M |
| Return on Equity (TTM) | Upgrade |
View All IMUC News
IMUC News
-
WireHeadlineTime (ET)
-
Yahoo04/16 07:50
-
MT Newswires04/12 08:47
-
SA Breaking News04/12 07:56
-
MT Newswires04/12 07:17
-
PR Newswire04/12 06:00
-
PR Newswire03/26 06:00
-
Yahoo03/14 21:11
-
MT Newswires03/13 17:53
-
MT Newswires03/13 16:19
-
SA Breaking News03/13 16:07
View All Events
IMUC Events
| Date | Type | Description |
|---|---|---|
| 03/09/2018 | Misc | ImmunoCellular Therapeutics Ltd Fourth Quarter Earnings Conference Call in 2017 |
| 03/09/2018 | Earnings | ImmunoCellular Therapeutics Ltd Fourth Quarter Earnings Results in 2017 |
| 11/21/2017 17:00 EST | Misc | ImmunoCellular Therapeutics Ltd Third Quarter Earnings Conference Call in 2017 |
| 11/21/2017 | Earnings | ImmunoCellular Therapeutics Ltd Third Quarter Earnings in 2017 Release |
| 08/23/2017 17:00 EDT | Misc | ImmunoCellular Therapeutics Ltd Second Quarter Earnings Conference Call in 2017 |
| 08/23/2017 | Earnings | ImmunoCellular Therapeutics Ltd Second Quarter Earnings in 2017 Release |
| 05/15/2017 | Earnings | ImmunoCellular Therapeutics Ltd First Quarter Earnings in 2017 Release |
| 05/15/2017 | Misc | ImmunoCellular Therapeutics Ltd First Quarter Earnings Conference Call in 2017 |
IMUC Fundamentals
Income Statement View Statement
IMUC Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
IMUC One Page Reports
- One Page Report Download
IMUC Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 0.2702 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.imuc.com
- Investor Relations URL: http://investors.imuc.com/index.cfm
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: N/A
- Last Earnings Release: Mar. 09, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: ImmunoCellular Therapeutics Ltd is engaged in developing immune-based therapies for the treatment of cancers which can elicit an immune response against several antigens.
IMUC Excel Add-In Codes
- Name: =YCI("IMUC","name")
- Description: =YCI("IMUC","description")
- Sector: =YCI("IMUC","sector")
- Industry: =YCI("IMUC","industry")
- Est. Current Fiscal Year End: =YCI("IMUC","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other IMUC Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- IMUC Tweets Stocktwits
Advertisement
